7
29
23
Selected Publications
148
Sandorfi, N, Shea L, Keenan A, Adamson E, Zazzetti F, Chakravarty S, Gotshall D, Gandhi J, Ranjan S, Akpek E, : A Systematic Literature Review on the Economic Burden of Sjögren’s Disease. ACR Convergence Annual Meeting Abstract Number: 1376, Nov 2025.
135
Johr CR, George MD, Bunya VY, Sandorfi N, Massaro-Giordano M, Vivino FB: Diagnostic Utility of Testing for Novel Murine Autoantibodies for Sjögren's Disease in the Rheumatology Outpatient Setting. Arthritis Care Res (Hoboken) Nov 2025.
156
Akpek E, Adamson E, Shea L, Zazzetti F, Chakravarty S, Ranjan S, Potluri R, Keenan A: Humanistic Burden of Sjögren’s Disease: A Systematic Review of Treatment Efficacy on Health-Related Quality-of-Life. ACR Convergence Annual Meeting Abstract Number: 1377, Nov 2025.
147
Lee, S, Johr C, Sandorfi N, Dhanaliwala A, DiRenzo D: Implementation of Salivary Gland Ultrasound by General Radiology can Improve Detection of Glandular Inflammation in Patients with Sicca. ACR Convergence Annual M Page: Abstract Number: 0520, Nov 2025.
1a3
Mehmetoglu E, Mummadisetty A, Chatzittofis A, Parperis K, Sandorfi N, Derk CT.: Rebuttal for letter to the editor from Miss Nassar and Dr Thombs regarding: "A systematic review of prevalence and predictors of depression in systemic sclerosis based on the CES-D, BDI, and PHQ-9 self-assessment questionnaires". Clin Rheumatol 8: 3387, Aug 2025.
252
Luo Y, Assassi S, Mayes MD, Frech TM, Steen VD, Richardson C, Chung L, Sandorfi N, VanBuren JM, Harding M, Alvey JS, Skaug B, McMahan ZH, Lakin KS, Zahn C, Bracken SJ, Lebiedz-Odrobina DJ, Molitor JA, Evnin LB, Moore DF, Shah A, Castelino FV, Volkmann ER, Hant FN, Makol A, Shah AA, Hummers LK, Gordon JK, Khanna D, Bernstein EJ: Use of Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease at Expert Scleroderma Centers in the United States. Ann Am Thorac Soc. 8: 1265-1269, Aug 2025.
175
Mehmetoglu E, Mummadisetty A, Chatzittofis A, Parperis K, Sandorfi N, Derk CT: A systematic review of prevalence and predictors of depression in systemic sclerosis based on the CES-D, BDI, and PHQ- 9 self-assessment questionnaires. . 2025 Jun;44(6):2327-2341. Clin Rheumatol 6: 2327-2341, Jun 2025.
28e
Hanif I, Assassi S, Mayes MD, McMahan ZH, Zhang M, Charles J, VanBuren JM, Alvey JS, Ghaffari K, Bernstein EJ, Castelino FV, Chung L, Evnin L, Frech TM, Gordon JK, Hant FN, Hummers LK, Khanna D, Lakin KS, Lebiedz-Odrobina D, Luo Y, Makol A, Molitor JA, Moore DF, Richardson C, Sandorfi N, Shah AA, Shah A, Shanmugam VK, Steen VD, Volkmann ER, Zahn C, Skaug B.: Hand Swelling and Other Non-Raynaud Phenomenon Symptoms as the Initial Presentation of Systemic Sclerosis: Prevalence and Clinical Associations in Two US Cohorts Arthritis Rheumatol Page: 19:10.1002/art.43237, May 2025.
130
Hajnoczky N, Levin LS, Sandorfi N, Derk CT: Long-term outcomes of vascular grafting of medium-sized vessels of wrist and hand in systemic sclerosis patients with medication refractory Raynaud's. J.Scleroderma Relat Disord Apr 2025.
24c
Yu JM, VanBuren JM, Child A, Alvey JS, Mandl LA, Pinheiro LC, Assassi S, Bernstein EJ, Castelino FV, Chung L, Evnin L, Frech TM, Hant FN, Hummers LK, Khanna D, Lakin KS, Lebiedz-Odrobina D, Luo Y, Makol A, Molitor JA, Moore DF, Richardson C, Sandorfi N, Shah AA, Shah A, Shanmugam VK, Skaug B, Steen VD, Volkmann ER, Gordon JK.: Psychometric Evaluation of the Scleroderma Skin Questionnaire: A Novel Patient-Reported Outcome for Skin Disease in Patients With Systemic Sclerosis. J Rheumatol. 3: 263-269, Mar 2025.
2c
7
1d
2c
back to top
26
Last updated: 01/27/2026
34
The Trustees of the University of Pennsylvania
c
1f